A phase I and pharmacokinetic study of the quinoxaline antitumour Agent R(+)XK469 in patients with advanced solid tumours

PURPOSE: To investigate the safety and pharmacokinetics of R(+)XK469, a quinoxaline analogue, in patients with advanced refractory solid tumours. Preclinical studies suggested that efficacy was independent of schedule but that toxicity was decreased by dividing the dose. METHODS: R(+)XK469 was initi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Undevia, Samir D., Innocenti, Federico, Ramirez, Jacqueline, House, Larry, Desai, Apurva A., Skoog, Linda A., Singh, Deepti A., Karrison, Theodore, Kindler, Hedy L., Ratain, Mark J.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2008
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2731567/
https://ncbi.nlm.nih.gov/pubmed/18650079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2008.05.018
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items